Literature DB >> 15035850

Loss of interferon-induced Stat1 phosphorylation in activated T cells.

C Justin Van De Wiele1, Julie H Marino, Michael E Whetsell, Stephen S Vo, Rhonda M Masengale, T Kent Teague.   

Abstract

Modulation of cytokine responsiveness following T cell activation represents an important mechanism that shapes the fate of T cells after encounters with antigens. We activated T cells in mice with superantigen and assessed their ability to phosphorylate Stat1 in response to interferon-gamma (IFN-gamma) and IFN-alpha. After 4 h of activation in vivo, T cells became deficient in their ability to phosphorylate Stat1 in response to either cytokine. The loss of IFN sensitivity was accompanied by increased mRNA transcription for multiple suppressors of cytokine signaling (SOCS) genes (SOCS1, SOCS3, and SOCS7). The transcript levels of these SOCS were elevated only during the early hours after activation and were at or below normal levels by 60 h. Likewise, the activation-induced inhibition of IFN-alpha signaling was transient, and sensitivity was restored by 3 days postactivation. The loss of sensitivity to IFN-gamma persisted, however, and was still evident at 3 days. These data suggest that SOCS-independent mechanisms specific for inhibition of IFN-gamma signaling may be present at later stages of the T cell response. The loss of Stat1 signaling may be a factor in differentiation of T cells during and after activation, and it could also represent a protective mechanism against the toxic effects of IFN-gamma during immune responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15035850     DOI: 10.1089/jir.2004.24.169

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  8 in total

1.  The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T cell populations by preventing interferon-gamma-induced cell death.

Authors:  Carl G Feng; Lixin Zheng; Dragana Jankovic; André Báfica; Jennifer L Cannons; Wendy T Watford; Damien Chaussabel; Sara Hieny; Patricia Caspar; Pamela L Schwartzberg; Michael J Lenardo; Alan Sher
Journal:  Nat Immunol       Date:  2008-09-21       Impact factor: 25.606

Review 2.  Regulation of antiviral T cell responses by type I interferons.

Authors:  Josh Crouse; Ulrich Kalinke; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2015-03-20       Impact factor: 53.106

3.  Disruption of thymopoiesis in ST6Gal I-deficient mice.

Authors:  Julie H Marino; Chibing Tan; Brenda Davis; Eun-Soo Han; Morgan Hickey; Rebecca Naukam; Ashlee Taylor; Kenton S Miller; C Justin Van De Wiele; T Kent Teague
Journal:  Glycobiology       Date:  2008-06-05       Impact factor: 4.313

4.  Janus-kinase-3-dependent signals induce chromatin remodeling at the Ifng locus during T helper 1 cell differentiation.

Authors:  Min Shi; Tsung H Lin; Kenneth C Appell; Leslie J Berg
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

5.  Differential IL-7 responses in developing human thymocytes.

Authors:  Julie H Marino; Chibing Tan; Ashlee A Taylor; Caroline Bentley; C Justin Van De Wiele; Richard Ranne; Marco Paliotta; Thomas A Broughan; T Kent Teague
Journal:  Hum Immunol       Date:  2010-01-25       Impact factor: 2.850

6.  Impaired thymopoiesis in interleukin-7 receptor transgenic mice is not corrected by Bcl-2.

Authors:  C Justin Van de Wiele; Julie H Marino; Chibing Tan; Hilary A Kneale; John Weber; John N Morelli; Brenda K Davis; Ashlee A Taylor; T Kent Teague
Journal:  Cell Immunol       Date:  2008-03-05       Impact factor: 4.868

Review 7.  Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.

Authors:  I-Tsu Chyuan; Hong-Tai Tzeng; Ji-Yih Chen
Journal:  Cells       Date:  2019-08-23       Impact factor: 6.600

8.  Control of T helper cell differentiation through cytokine receptor inclusion in the immunological synapse.

Authors:  Roberto A Maldonado; Michelle A Soriano; L Carolina Perdomo; Kirsten Sigrist; Darrell J Irvine; Thomas Decker; Laurie H Glimcher
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.